Karolinska University Hospital / Karolinska Universitetssjukhuset

Hodgkin lymphoma: hypodense lesions in mediastinal masses (2024) Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, et al. Journal article METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy (2024) Beckmann K, Reitinger C, Yan X, Carle A, Blümle E, Jurkschat N, Paulmann C, et al. Journal article Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group (2024) Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, et al. Journal article Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges (2024) Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, et al. Journal article Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023) (2024) De Mendoza C, Taylor G, Gessain A, Thoma-Kreß A, Bangham C, Vesterbacka J, Accolla R, et al. Journal article Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies (2024) Kadam E, Javaid M, Sen P, Saha S, Ziade N, Day J, Wincup C, et al. Journal article Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy (2024) Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, Parra RS, et al. Journal article COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. (2024) Andreoli L, Lini D, Schreiber K, Parodis I, Sen P, Ravichandran N, Day J, et al. Journal article Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 (2024) Pusztai L, Denkert C, O'Shaughnessy J, Cortes J, Dent R, McArthur H, Kümmel S, et al. Journal article